NKX3-2 and acute lymphoblastic leukemia: Furthermore, neither SIX6 nor NKX3-2 showed significant expression levels in normal hematopoietic cells including PBMCs, T-cells and B-cells, confirming their aberrant activity in T-ALL subsets.